HURA (TuHURA Biosciences) EBITDA Margin %: 0.00% (As of Mar. 2026)


HURA TuHURA Biosciences Inc HURA
12 GF Score
Price $2.59
! 1 Warning Sign
View Full Analysis

What is TuHURA Biosciences EBITDA Margin %?

TuHURA Biosciences HURA +2.57% 12 EBITDA Margin % is 0.00% as of Mar. 2026. GuruFocus rates HURA with a GF Score™ of 12/100. The stock has 1 warning sign investors should review. Among 945 Biotechnology companies, TuHURA Biosciences ranks worse than 105820% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. TuHURA Biosciences's EBITDA for the three months ended in Mar. 2026 was $-7.49 Mil. TuHURA Biosciences's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, TuHURA Biosciences's EBITDA margin for the quarter that ended in Mar. 2026 was 0.00%.

TuHURA Biosciences  (NAS:HURA) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

TuHURA Biosciences EBITDA Margin % Related Terms

TuHURA Biosciences EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for TuHURA Biosciences's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TuHURA Biosciences EBITDA Margin % Chart

TuHURA Biosciences Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
EBITDA Margin %
0.00 0.00 0.00 0.00 0.00

TuHURA Biosciences Quarterly Data
Dec21 Mar22 Dec22 Mar23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

HURA vs AGEN, CRBP, SPRB: EBITDA Margin % Comparison

For the Biotechnology subindustry, TuHURA Biosciences's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TuHURA Biosciences EBITDA Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TuHURA Biosciences's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where TuHURA Biosciences's EBITDA Margin % falls into.


HURA
12GF Score
TuHURA Biosciences Inc HURA
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TuHURA Biosciences EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

TuHURA Biosciences's EBITDA Margin % for the fiscal year that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-29.355/0
= %

TuHURA Biosciences's EBITDA Margin % for the quarter that ended in Mar. 2026 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-7.485/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
TuHURA Biosciences (HURA) has a EBITDA Margin % of 0.00% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on TuHURA Biosciences and its competitors. According to the industry distribution chart, TuHURA Biosciences ranks #999999 out of 945 companies in the Biotechnology industry.
Is TuHURA Biosciences' EBITDA Margin % too high?
TuHURA Biosciences' current EBITDA Margin % is 0.00%. Based on the distribution chart, TuHURA Biosciences ranks #999999 out of 945 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, TuHURA Biosciences has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does TuHURA Biosciences' EBITDA Margin % compare to AGEN and CRBP?
According to the Biotechnology industry distribution chart, TuHURA Biosciences ranks #999999 out of 945 companies for EBITDA Margin %. This places TuHURA Biosciences in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on TuHURA Biosciences and its competitors. TuHURA Biosciences's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TuHURA Biosciences stock overvalued right now?
TuHURA Biosciences (HURA) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. TuHURA Biosciences' overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For TuHURA Biosciences (HURA), the current EBITDA Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TuHURA Biosciences Business Description

Other Exchanges PL3:Germany
Address 10500 University Center Drive, Suite 110, Tampa, FL, USA, 33612
TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.
12GF Score

Get the complete analysis for HURA

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.59
Price